Biofil Chemicals & Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

16.27

16.27

16.27

16.27

16.27

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

1.03

0.56

-0.14

-1.39

-2.62

Loan funds

Secured loans

0.53

0.46

0.43

1.19

1.64

Unsecured loans

-

-

-

-

-

Total

17.83

17.30

16.56

16.08

15.29

Uses of funds

Fixed assets

Gross block

11.63

11.62

11.55

11.45

11.24

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

2.63

2.20

1.77

1.36

0.95

Net block

9.00

9.42

9.78

10.09

10.29

Capital work-in-progress

-

-

-

-

-

Investments

-

-

-

-

-

Net current assets

Current assets, loans & advances

22.41

9.31

23.46

32.27

13.92

Less : current liabilities & provisions

13.58

1.43

16.68

26.29

8.93

Total net current assets

8.83

7.88

6.78

5.98

4.99

Miscellaneous expenses not written

-

-

-

-

-

Total

17.83

17.30

16.56

16.08

15.29

Notes:

Book value of unquoted investments

-

-

-

-

-

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

162.74

162.74

162.74

162.74

162.74